CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 9, 2023 · earnings

XERS earnings: a negative outcome, -8.8%

On November 9, 2023, Xeris Biopharma Holdings, Inc. reached its earnings. The result was a negative outcome, and the stock moved -8.8% in the window around the event. It had already run +8.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$1.98
1d before
$1.80
Event day
$1.69
1d after
$1.56
5d after

Pre-catalyst setup

+8.2%
30-day run-up
9745%
30-day volatility
2.2×
volume spike